Current Options for Improvement of Treatment of Gastroesophageal Reflux Disease

S.M. Tkach

Abstract


The article is dedicated to the treatment of one of the most common pathologies in gastroenterology — gastroesophageal reflux disease. The use of proton pump inhibitors and their combination with prokinetics is being dwelt.


Keywords


gastroesophageal reflux disease; esophagitis; proton pump inhibitor; prokinetic

References


Исаков В.А. Фармакогенетический анализ метаболизма и клинической эффективности ингибиторов протонного насоса // Клин. фармакол. и тер. — 2003. — Т. 12, № 1. — С. 32-37.

Минушкин О.Н., Лощинина Ю.Н. Эффективность применения препарата Ганатон в лечении больных ГЭРБ // http://medi.ru/doc/272104.htm

Abid S., Mumtar K., Jafri W. et al. Pill-induced esophageal injuri: endoscopic features and clinical outcomes // Endoscopy. — 2005. — 37. — 470-4.

Adachi K., Katsube T., Kawamura A. et al. CYP2C19 genotype status and intragastric pH during dosing with lansoprazole or rabeprazole // Aliment. Pharmacol. Ther. — 2000. — 14 (10). — 1259-1266.

Amarapurkar D.N., Rane P. Randomised, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia // J. Ind. Med. Assoc. — 2004. — 102, № 12. — 735-737.

Dent J., Brun J., Fendrick A. et al. An evidence-based appraisal of reflux disease management // Genval Workshop Report. — 1999. — 44 Suppl. 2. — 1-16.

Ellison E.N., Wilson S.D. The Zoolinger-Ellison syndrome: Appraisal and evaluation of 260 registered cases // Ann. Sugr. — 1964. — V. 160, № 3. — P. 512-553.

Fachler W., Ouss T., Valzi M., Richter J. Long-term effect of H2-RA therapy on nocturnal gastric acid breakthrough // Gastroenterology. — 2002. — 122. — 625-32.

Fox V., Nurko S., Furuta G. Eosiniphilic esophagitis: it’s not just kids stuff // G.J. Endoscopy. — 2002. — 56. — 260-70.

Holtmann G., Talley N.J., Liebregts T. et al. A placebo-controlled trial of itopride in functional dyspepsia // New Engl. J Med. — 2006. — Vol. 23, № 354. — P. 832-840.

Horai Y., Kimura M., Furuie H. Et al. Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes // Aliment. Pharmacol. Ther. — 2001. — 15. — 805-812.

Inoue K., Sanada Y., Fijimura J., Mihara O. Clinical effect of itopride hydrochloride on the digestive symptoms of chronic gastritis with reflux esophagitis // Clin. Med. — 1999. — Vol. 15. — P. 1803-1808.

Johnsson F., Weywadt L., Solhaug J.H. et al. One week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease // Scand. J. Gastroenterol. — 1998. — 33. — 15-20.

Kahrilas P. Diаgnosis of Symptomatic Gastroesophageal Reflux Disease // Am. J. Gastroenterol. — 2003. — 98. — 15-23.

Kamath S., Vinod K., Verghese J., Bhatia Sh. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia // JAMA. — 2003. — Vol. 2, № 8. — P. 95-98.

Katagiri F., Shiga T., Inoue S. et al. Effects of itopride hydrochloride on plasma gut-regulatory peptide and stressrelated hormone levels in healthy human subjects // Pharmacology. — 2006. — Vol. 77, № 3. — Р. 115-21.

Kim Y.S., Kim T.H., Choi C.S. et al. Effect of itopride, a new prokinetic, in patients with moderate GERD: A pilot study // World J. Gastroenterol. — 2005. —Vol. 11, № 27. — P. 4210-4214.

Laine L., Bombardier C., Hawkey C.J. Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis // Gastroenterology. — 2002. — 123. — 1006-12.

Mahmood Z., McNamara D. Gastro-oesophageal reflux disease and ulcer disease in Europe // Tne Burden of Gastrointestinal Disease in Europe, UEGF. — 2004. — Р. 31-36.

Richter J. The refractory GERD patient // World Gastroenterol. News. — 2007. — Vol. 12. — 11-13.

Mushiroda T., Douya R., Takahara E. et al. The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride, a gastroprokinetic agent: comparison with cisapride and mosapride citrate // Drug Metabol. Dispos. — 2000. — № 28. — Р. 1231-1237.

Schenk B.E., Kuipers E.J., Klinkenberg-Knol E.C. et al. Omeprazole as a diagnostic tool in gastro-esophageal

reflux disease // Am. J. Gastroenterol. — 1997. — 92. — 1997-2000.

Sawant P., Das H.S., Desai N. et al. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia // Am. J. Gastroenterol. — 2004. — Vol. 52. — P. 626-628.

Stedman C.A.M., Barclay M.L. Rewiev article: comparison of pharmacokinetiks, acid suppression and efficacy of proton pump inhibitors // Aliment. Pharmacol. Ther. — 2000. — 14. — 963-978.

Talley N.J., Tack J., Ptak T. et al. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials // Gut. — 2008. — № 57. — P. 740-746.

Tsubouchi Т., Saito T., Mizutani F. et al. Stimulatory action of itopride hydrochloride on colonic motor activity in vitro and in vivo // JPET. — 2003. — Vol. 2, № 306. —

Р. 787-793.

Van Pinxteren B., Numans M.E., Bonis P.A., Lau J. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetiks for gastro-oesophageal reflux disesase like symptoms and endoscopy negative reflux disease // Cochrane Database Syst. Rev. — 2004 Oct. 18 (4). — CD002095.

Vela M., Camacho L., Srinivasan H. et al. Simultaneous intraesophageal impendance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole // Gastroenterology. — 2001. — 120. — 1599-1606.

Wise J., Murray J. Esophageal manifestations of dermatologic diseases // Current Gastroenterol. Report. — 2002. — 4. — 205-12.




DOI: https://doi.org/10.22141/2308-2097.2.52.2014.81973

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 GASTROENTEROLOGY

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru